Categories: Underwriting
Topics: PruProtect| HIV| disease of the month
HIV/AIDS is still a major global killer. But, with medical advances in the west, what are the insurance implications? Fergus Bescoby investigates
HIV first emerged as a threat to humanity in the early 1980s. It spread so fast that initially there were fears that it might wipe us all out. Happily, there now seems no danger of that.
Genetic research indicates that HIV originated in west-central Africa during the late nineteenth or early twentieth century. AIDS was first recognised by the US Centers for Disease Control and Prevention in 1981 and its cause, HIV, identified in the early 1980s.
Over the past 27 years, nearly 25 million people have died from AIDS. HIV/AIDS causes debilitating illness and premature death in people during their prime years of life and has devastated families and communities.
In some countries, particularly those located in Sub-Saharan Africa, HIV rates are extremely high. For instance, in the Republic of South Africa it is estimated that about 11% of the population is HIV-positive.
Through unprecedented global attention and intervention, the rate of new HIV infections has slowed and prevalence rates have levelled off. However, despite the progress seen in some countries and regions, the total number of people living with HIV continues to rise.
As yet there is no cure for HIV/AIDS. Neither is there a vaccine to prevent HIV infection, however new medications are now available which slow the progression of the infection and consequently allow infected individuals the chance to lead a more normal life.
HIV stands for Human Immunodeficiency Virus and is a virus that takes over certain immune system cells to make many copies of itself. HIV causes slow but constant damage to the immune system.
Normally, the human immune system is the body’s protection against bacteria and viruses and can be likened to a coat of armour. When HIV enters the body, it starts poking holes in the armour and eventually weakens it to such an extent that it is unable to protect the body. Once the immune system or armour is very weak or is gone, the person is said to have AIDS.
AIDS stands for Acquired Immune Deficiency Syndrome and is the condition diagnosed when there are a group of related symptoms that are caused by advanced HIV infection or when someone has a CD4 (immune cells) count of less than 200. AIDS makes the body vulnerable to life-threatening illnesses called opportunistic infections.
The term AIDS was first used by doctors when the exact nature of the HIV virus was not fully understood. However, the term is no longer widely used because it is too general to describe the many different conditions that can affect somebody with HIV. Specialists now prefer to use the terms advanced or late-stage HIV infection.
An opportunistic infection is an infection that would not be life-threatening to an otherwise healthy person. Often it is these infections that are the cause of illness or death in HIV-positive individuals, not the virus itself.
In the absence of antiretroviral therapy, the median time of progression from HIV infection to AIDS is nine to ten years, and the median survival time after developing AIDS is only 9.2 months. However, the rate of clinical disease progression varies widely between individuals, from two weeks up to 20 years.
The rate of progression depends on certain factors that influence the body’s ability to defend against HIV such as the infected person’s general immune function. Older people have weaker immune systems, and therefore have a greater risk of rapid disease progression than younger people.
Poor access to health care and the existence of coexisting infections such as tuberculosis also may predispose people to faster disease progression.
The infected person’s genetic inheritance plays an important role and some people are resistant to certain strains of HIV. HIV is genetically variable and exists as different strains, which cause different rates of clinical disease progression.
As mentioned above, the symptoms of AIDS are primarily the result of conditions that do not normally develop in individuals with healthy immune systems. Most of these conditions are infections caused by bacteria, viruses or parasites that are normally controlled by the elements of the immune system that HIV damages. Opportunistic infections are common in people with AIDS and can affect nearly every organ system.
People with AIDS also have an increased risk of developing various cancers such as Kaposi’s sarcoma, cervical cancer and cancers of the immune system known as lymphomas.
Additionally, people with AIDS often have systemic symptoms of infection like fevers, sweats (particularly at night), swollen glands, chills, weakness, and weight loss. The specific opportunistic infections that AIDS patients develop depend in part on the prevalence of these infections in the geographic area in which the patient live. More mention is made of associated medical conditions later in the box above.
Screening for HIV infection is most commonly done by testing blood for HIV antibodies, however more recently other methods have been introduced. These include collecting secretions from between the cheek and gum for evaluation and also urine testing. The latter two methods are often favoured as they eliminate the need for a needle stick, although a blood test may still be required in the event of a positive test.
HIV is transmitted through four body fluids: blood, semen, vaginal fluid, and breast milk. In order to pass HIV from one person to another, HIV-infected fluid from one person needs to get into the bloodstream of another person. HIV is usually transmitted through sharing needles, unprotected anal, vaginal, and sometimes oral sex, and from mother to infant before or during delivery or while breastfeeding.
A tiny number of cases occur for other reasons, for instance as a result of blood transfusion and organ donation or sperm donation from a person who is HIV-positive. HIV cannot be transmitted by touching someone or sharing items, such as cups or pencils or through coughing and sneezing. Additionally it cannot be spread through routine contact in restaurants, the workplace or schools.
Although treatments for AIDS and HIV can slow the course of the disease, there is currently no vaccine or cure. Antiretroviral treatment reduces both the mortality and the morbidity of HIV infection, but these drugs are expensive and routine access to antiretroviral medication is not available in all countries. Due to the difficulty in treating HIV infection, preventing infection is a key aim in controlling the AIDS pandemic.
Anti-HIV (also called antiretroviral) medications are used to control the reproduction of the virus and to slow or halt the progression of HIV-related disease. When used in combinations, these medications are termed Highly Active Antiretroviral Therapy (HAART). HAART combines three or more anti-HIV medications in a daily regimen, sometimes referred to as a ‘cocktail’.
Anti-HIV medications do not cure HIV infection and individuals taking these medications can still transmit HIV to others. They also have side effects which can vary in severity and include decreased levels of red or white blood cells, inflammation of the pancreas, liver toxicity, rash, gastrointestinal problems, elevated cholesterol level, diabetes, abnormal body-fat distribution and painful nerve damage.
An HIV test is requested as part of the standard non-medical limit within most companies. The actual amount varies but is generally requested at around the £1m level.
Due to the nature of the disease the majority of insurance companies do not offer straightforward life insurance cover to individuals who are HIV positive, although PruProtect currently offer a maximum of £250,000 life cover to clients who meet certain criteria. This is deemed a step in the right direction and has been welcomed by the industry.
Fergus Bescoby is underwriting development manager at PruProtect
| Share | |
| Comment | Disease of the Month: HIV/AIDS |
More from cover
Email alerts
Recommended reading
Categories
Topics
Comments
Related articles
Most Read
This year we have 14 awards designed to mark out the very best products in a highly competitive and innovative market. This includes three new awards for 2011 to reflect the developments in this rapidly growing market: Best Dual/Multi-Index Product, Best Structured (Oeic) Fund and Best Structured Product Provider.
Events
Poll
|
|
Job search
Ifaonlinejobs will open the right investment career path for you. Search hundreds of vacancies on www.ifaonlinejobs.co.uk now
In Focus
Transferring clients’ assets between organisations can be a major headache – often time...
Viewpoints
At the start of one of busiest times of year it is easy to think about all the obvious things...
There are no comments submitted yet. Do you have an interesting opinion? Then be the first to post a comment